View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Moody's Ratings says R1 RCM's planned acquisition by Towerbrook has no...

Moody's Ratings (Moody's) said that R1 RCM, Inc.'s ("R1 RCM") announcement that it signed a definitive merger agreement to be acquired by affiliates of TowerBrook Capital Partners ("TowerBrook") and Clayton Dubilier & Rice ("CD&R") has no immediate impact to R1 RCM's negative outlook and ratings, in...

R1 RCM Inc.: Potential acquisition offer from New Mountain Capital is ...

The unsolicited offer for R1 RCM is a credit negative as we believe there is a risk it may result in higher leverage

Moody's says potential acquisition offer from New Mountain Capital is ...

Moody's Investors Service ("Moody's") said that the announcement by R1 RCM, Inc.'s ("R1" or "the company") that an investor group led by New Mountain Capital L.L.C. ("New Mountain"), representing certain managed funds, is considering making an offer to acquire all outstanding shares of R1 is a credi...

R1 RCM Inc.: Update following Acclara acquisition and downgrade to Ba3

Our credit view of this issuer reflects its customer concentration and high debt.

Moody's downgrades R1 RCM's CFR to Ba3 from Ba2 on Acclara acquisition...

Moody's Investors Service ("Moody's") downgraded the corporate family rating (CFR) of R1 RCM, Inc. ("R1") to Ba3 from Ba2 and its probability of default ("PDR") to Ba3-PD from Ba2-PD. At the same time, Moody's assigned a Ba3 rating to the company's newly proposed $500 million term loan B due 2029 an...

Moody's says R1's filing delay and financial restatements are credit n...

Moody's Investors Service ("Moody's") said that R1 RCM Inc.'s ("R1") announcement of the postponement of its quarterly 10-Q filing for the three and nine months ended 30 September 2023 and the restatement of its previously issued financial statements for the years ended December 31, 2022 and 2021 an...

R1 RCM Inc.: Update to credit analysis following change in outlook to ...

Our credit view of this issuer reflects its sizable revenue base reaching $2.2 billion in 2023, constrained by its high debt leverage and modest free cash flow.

Moody's affirms R1 RCM's Ba2 CFR and Ba2 senior secured debt ratings, ...

Moody's Investors Service ("Moody's") affirmed the ratings at R1 RCM Inc. ("R1"), a provider of technology-driven healthcare revenue cycle management ("RCM") services, including its Ba2 corporate family rating ("CFR") and Ba2-PD probability of default ("PDR"). Additionally, Moody's affirmed the comp...

New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch